Female, male, T2, T3, N1-N3, M1, M0 and Her-2-negative cancer patients with high Becn1 mRNA expression had a high overall survival rate than those with its low expression (P<0.05), while it was the same for progression-free survival rate in the male, T2, T4, N1-3, N1, M0, Her2-negative and -positive cancer patients (P<0.05). Here, ERBB2 is linked to cancer.